GSK PLC (NYSE:GSK)
$ 44.435 0.295 (0.67%) Market Cap: 90.60 Bil Enterprise Value: 106.24 Bil PE Ratio: 17.47 PB Ratio: 5.26 GF Score: 79/100

GlaxoSmithKline PLC at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 01:35PM GMT
Release Date Price: $36.6 (+1.42%)
Emily Field
Barclays Bank PLC, Research Division - Research Analyst

Sorry, I was muted there. Welcome, everybody. My name is Emily Field. I am the European Pharmaceuticals Analyst here at Barclays. And we are delighted to be hosting, from GSK, the CEO of ViiV Healthcare, Deborah Waterhouse. And Deborah will provide a few opening remarks before we get into a Q&A fireside chat style.

So Deborah, over to you.

Deborah Jayne Waterhouse
GlaxoSmithKline plc - CEO of ViiV Healthcare

Thanks, Emily. Thanks for inviting me to do this fireside chat today. So just a few opening comments. So 2020 was a strong year for ViiV Healthcare in terms of innovation, performance and our trust objectives. We delivered 1% growth in the year, and that was accelerated in quarter 4 to 2% top line growth.

We have just been through 2 years of the business being broadly flat. And I'm delighted to be able to say that we're now moving back to progressive acceleration in growth, and that's really underpinned by the continued expansion of our 2-drug regimen portfolio,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot